Files in This Item:


Title: Effect of gender on reporting of MMR adverse events in Saudi Arabia
Authors: Khalil, M.K.
Al Mazrou, Y.Y.
Al Ghamdi, Y.S.
Tumsah, S.
Al Jeffri, M.
Meshkhas, A.
Issue Date: 2003
Language: English
Abstract: We evaluated the safety of a measles-mumps-rubella [MMR] immunization campaign for Saudi children [age range: 6-13 years] and gender differences in reporting post-MMR adverse events. After vaccinations were administered, we monitored 160 schools for 14 days and 19 hospitals in the 8 cities under study for 10 weeks. Incidence rates were: all MMR adverse events, 26.5/10,000 MMR vaccines [significantly higher in females than males]; Urabe strain aseptic meningitis, 1.0/295,000; fever, 40.2/10,000 [females] and 0.9/10,000 [males]; and parotitis, 5.4/10,000 [females] and 0.9/10,000 [males]. Combined MMR vaccine containing the Urabe mumps strain was safe for children aged 6-13 years. Gender differences regarding reactogenicity were evident and should be considered when designing future studies
Description: 152-158
Keywords: Adverse Drug Reaction Reporting Systems
Data Collection
Drug Hypersensitivity
Immunization Programs
Sex Distribution
Metabolic Clearance Rate
Subject: Vaccines
ISSN: 1020-3397
Other Identifiers:
Appears in Collections:EMRO Journal Articles (EMHJ)

Items in WHO IRIS are protected by copyright, with all rights reserved, unless otherwise indicated.